ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACLY | ATP citrate lyase | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AKAP12 | A kinase (PRKA) anchor protein 12 | Cancer-related genes Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
ALCAM | Activated leukocyte cell adhesion molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
ALDOA | Aldolase A, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ANXA11 | Annexin A11 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ANXA4 | Annexin A4 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BAX | BCL2-associated X protein | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
C1QBP | Complement component 1, q subcomponent binding protein | Cancer-related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CALR | Calreticulin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Mixed |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CCNA2 | Cyclin A2 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD38 | CD38 molecule | Cancer-related genes CD markers Enzymes Predicted intracellular proteins
| | | | | Mixed |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD59 | CD59 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CDC34 | Cell division cycle 34 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CDC37 | Cell division cycle 37 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDK6 | Cyclin-dependent kinase 6 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CKB | Creatine kinase, brain | Cancer-related genes Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CLDN4 | Claudin 4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CREBBP | CREB binding protein | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CSE1L | CSE1 chromosome segregation 1-like (yeast) | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CSNK2B | Casein kinase 2, beta polypeptide | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CTAG1A | Cancer/testis antigen 1A | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CTSD | Cathepsin D | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CTSH | Cathepsin H | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |